These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 26529926)

  • 21. Bone turnover markers: use in osteoporosis.
    Naylor K; Eastell R
    Nat Rev Rheumatol; 2012 Jun; 8(7):379-89. PubMed ID: 22664836
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thalassemic osteopathy: a new marker of bone deposition.
    Baldini M; Forti S; Orsatti A; Marcon A; Ulivieri FM; Airaghi L; Zanaboni L; Cappellini MD
    Blood Cells Mol Dis; 2014; 52(2-3):91-4. PubMed ID: 24091145
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The use of biomarkers in clinical osteoporosis.
    Cabral HW; Andolphi BF; Ferreira BV; Alves DC; Morelato RL; Chambo A; Borges LS
    Rev Assoc Med Bras (1992); 2016 Jul; 62(4):368-76. PubMed ID: 27437684
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of yearly zoledronic acid 5 mg on bone turnover markers and relation of PINP with fracture reduction in postmenopausal women with osteoporosis.
    Delmas PD; Munoz F; Black DM; Cosman F; Boonen S; Watts NB; Kendler D; Eriksen EF; Mesenbrink PG; Eastell R;
    J Bone Miner Res; 2009 Sep; 24(9):1544-51. PubMed ID: 19338427
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of pharmaceutical care on adherence and persistence to bisphosphonates in postmenopausal osteoporotic women.
    Lai PS; Chua SS; Chew YY; Chan SP
    J Clin Pharm Ther; 2011 Oct; 36(5):557-67. PubMed ID: 21916908
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Insight into the potential of bone turnover biomarkers: integration in the management of osteoporosis and chronic kidney disease-associated osteoporosis.
    Brouwers P; Bouquegneau A; Cavalier E
    Curr Opin Endocrinol Diabetes Obes; 2024 Aug; 31(4):149-156. PubMed ID: 38804196
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk assessment for osteoporosis. II. Biochemical markers of bone turnover: bone resorption indices.
    Woitge HW; Seibel MJ
    Clin Lab Med; 2000 Sep; 20(3):503-25, vi. PubMed ID: 10986618
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The clinical utility of bone marker measurements in osteoporosis.
    Wheater G; Elshahaly M; Tuck SP; Datta HK; van Laar JM
    J Transl Med; 2013 Aug; 11():201. PubMed ID: 23984630
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Use of Bone-Turnover Markers in Asia-Pacific Populations.
    Vasikaran S; Thambiah SC; Tan RZ; Loh TP;
    Ann Lab Med; 2024 Mar; 44(2):126-134. PubMed ID: 37869778
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reference intervals of biochemical bone turnover markers for Saudi Arabian women: a cross-sectional study.
    Ardawi MS; Maimani AA; Bahksh TA; Rouzi AA; Qari MH; Raddadi RM
    Bone; 2010 Oct; 47(4):804-14. PubMed ID: 20659600
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical utility of bone turnover markers in patients with chronic kidney disease.
    Smout D; Jørgensen HS; Cavalier E; Evenepoel P
    Curr Opin Nephrol Hypertens; 2022 Jul; 31(4):332-338. PubMed ID: 35703216
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Markers of bone turnover: consideration on their clinical application in osteoporosis.
    Cantatore FP; Pipitone V
    Panminerva Med; 1999 Sep; 41(3):247-51. PubMed ID: 10568124
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alfacalcidol reduces accelerated bone turnover in elderly women with osteoporosis.
    Shiraki M; Fukuchi M; Kiriyama T; Okamoto S; Ueno T; Sakamoto H; Nagai T
    J Bone Miner Metab; 2004; 22(4):352-9. PubMed ID: 15221494
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinical use of biological markers of bone turnover in osteoporosis].
    Bergmann P
    Rev Med Brux; 2008 Sep; 29(4):295-300. PubMed ID: 18949980
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Biochemical markers of bone turnover. New aspect. An automated assay for measuring bone turnover markers].
    Miura M
    Clin Calcium; 2009 Aug; 19(8):1160-9. PubMed ID: 19638700
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Towards optimising the provision of laboratory services for bone turnover markers.
    Vasikaran SD; Chubb SA; Schneider HG
    Pathology; 2014 Jun; 46(4):267-73. PubMed ID: 24798169
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Biochemical markers of bone turnover : clinical usefulness in osteoporosis].
    Garnero P; Delmas PD
    Ann Biol Clin (Paris); 1999; 57(2):137-48. PubMed ID: 10210740
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Outline of Guidelines 2004 for bone marker in osteoporosis].
    Nishizawa Y
    Nihon Rinsho; 2007 Nov; 65 Suppl 9():37-41. PubMed ID: 18161079
    [No Abstract]   [Full Text] [Related]  

  • 39. Bone Turnover Markers in the Diagnosis and Monitoring of Metabolic Bone Disease.
    Greenblatt MB; Tsai JN; Wein MN
    Clin Chem; 2017 Feb; 63(2):464-474. PubMed ID: 27940448
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bi-directionally selective bone targeting delivery for anabolic and antiresorptive drugs: a novel combined therapy for osteoporosis?
    Liu J; Zhang H; Dong Y; Jin Y; Hu X; Cai K; Ma J; Wu G
    Med Hypotheses; 2014 Dec; 83(6):694-6. PubMed ID: 25459136
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.